Allergy & Eosinophil Rothenberg CURED Research Lab at Cincinnati Children's

04/06/2026

Publications authored by our division faculty and fellows published in print in March 2026!

Sequencing and health data resource of children of African ancestry
https://pubmed.ncbi.nlm.nih.gov/41793414/

The age of eczema onset and multiple food allergies
https://pubmed.ncbi.nlm.nih.gov/41349694/

Gene regulatory network determinants of rapid recall in human memory CD4+ T cells
https://pubmed.ncbi.nlm.nih.gov/41865369/

We present the acquisition and quality of genetic and disease-associated data and present an analytical framework for using this resource. In partnership with a community advisory council, we have codeveloped a valuable framework for data use and future research.

04/03/2026

https://scienceblog.cincinnatichildrens.org/eoe-the-fifth-member-of-the-atopic-march/?utm_source=rss&utm_medium=rss&utm_campaign=eoe-the-fifth-member-of-the-atopic-march

Children with early-life atopic dermatitis (AD) are at a higher risk of developing other atopic comorbidities, including eosinophilic esophagitis (EoE). A recent study in the Journal of Allergy and Clinical Immunology, published February 2026, shows that children with AD within the first two years o...

04/02/2026

https://scienceblog.cincinnatichildrens.org/single-cell-study-reveals-how-immune-memory-cells-remember-threats/?utm_source=rss&utm_medium=rss&utm_campaign=single-cell-study-reveals-how-immune-memory-cells-remember-threats

Scientists at Cincinnati Children’s have identified how certain immune cells are molecularly programmed to respond faster when the body encounters a familiar threat, shedding light on immune memory and its links to diseases such as asthma, multiple sclerosis and inflammatory bowel disease.

03/18/2026

The video highlights the Cincinnati Center for Eosinophilic Disorders at Cincinnati Children’s, describing how exceptional patient care is driven by groundbr...

03/04/2026

Publications authored by our division faculty and fellows published in print in February 2026!

Updates in Pediatric Drug Allergy
https://pubmed.ncbi.nlm.nih.gov/41706240/

The Diagnosis of Non-Allergic Rhinitis
https://pubmed.ncbi.nlm.nih.gov/41241424/

Immune Functions of the Esophagus
https://pubmed.ncbi.nlm.nih.gov/41386478/

B-Cell Repertoire of Children With Atopic Dermatitis Exhibits Altered IgE Maturation Associated With Allergic Food Sensitization
https://pubmed.ncbi.nlm.nih.gov/41216705/

Epinephrine and Emergency Medical Services Activation Recommendations During Acute Allergic Reactions in Community Settings: International Consensus Report
https://pubmed.ncbi.nlm.nih.gov/41386477/

Decidual CD4 Effector Memory and Resident Memory T Cells Respond to Cord Blood Allo-Antigens
https://pubmed.ncbi.nlm.nih.gov/41618722/

Thus, decidual CD4 TEM and TRM have unique immune effector functions and the ability to recognize and respond to fetal cord blood. This suggests that decidual CD4 TEM and TRM cells can recognize fetal allo-antigens and, when not adequately controlled, may....

02/28/2026

One size doesn’t fit all in rare disease care, and thousands of rare conditions impact 300 million people worldwide. On this , explore the breakthroughs, stories, and the science driving hope for families:

The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, diagnosis, or treatment. Email researchnews@cchmc.org with questions or ideas.

02/23/2026

02/16/2026

Congratulations to the Center for Inflammation and Tolerance, including our division faculty Ty Troutman and Nurit Azouz, for being selected to receive the Research Team Award for Cincinnati Children’s 15th Annual Faculty Awards!

The Center for Inflammation and Tolerance (CIT) at Cincinnati Children’s is a multidisciplinary team of scientists performing discovery and translational research.

02/06/2026

22 Days until Rare Disease Day!

⏰ The countdown continues, just ONE MONTH until Rare Disease Day!

🌍 Next month, on 28 February, people around the world will come together to raise awareness, celebrate the rare disease community, and show that we are stronger together.

Whatever activities you have planned can be posted on our website such as lighting up your home or a landmark. Keep sharing your story and activities online and spreading awareness.

Haven’t started yet? Explore our website to discover ways to participate and connect with others across the globe: https://go.rarediseaseday.org/RDD

Let’s make Rare Disease Day 2026 more than you can imagine. 💪

02/05/2026

We are so grateful for our partnership with CURED Nfp - Campaign Urging Research for Eosinophilic Diseases and changing the outcome together for eosinophilic disease!

CURED is honored to make our third donation of the year—$25,000 to the Rothenberg CURED Lab. This milestone is only possible because of your continued support. Together, we are transforming outcomes and bringing hope to patients living with eosinophilic diseases.

02/04/2026

Publications authored by our division faculty and fellows published in print in January 2026!

Immune pathways and prenatal/perinatal environmental exposures contribute to epigenetic gestational age prediction and acceleration
https://doi.org/10.1080/15592294.2025.2610521

Direct challenges are safe and effective in children with low-risk allergies to oral cephalosporins
https://doi.org/10.1016/j.jaip.2025.10.008

CisBP-RNA: a web resource for eukaryotic RNA-binding proteins and their motifs
https://doi.org/10.1093/nar/gkaf1081

Cendakimab (anti-IL-13) administration improves esophageal gene expression in eosinophilic esophagitis
https://doi.org/10.1016/j.jaci.2025.08.032

Artificial intelligence in the detection and management of eosinophilic gastrointestinal diseases: Applications, challenges, and future outlook
https://doi.org/10.1016/j.jaci.2025.08.020

01/28/2026

This video highlights our amazing accomplishments over the last year.

Thank you for being part of our community and supporting the work we do every day. Your continued support allows us to do what matters most, helping patients and families with allergic disease.

Here at Cincinnati Children’s, we believe in sharing our ideas, our discoveries, and our advancements. Here are a few recent research highlights from 2025 fo...